243 related articles for article (PubMed ID: 32407265)
1. Effect of Green Tea and (-)-Epigallocatechin Gallate on the Pharmacokinetics of Rosuvastatin.
Huang S; Xu Q; Liu L; Bian Y; Zhang S; Huang C; Miao L
Curr Drug Metab; 2020; 21(6):471-478. PubMed ID: 32407265
[TBL] [Abstract][Full Text] [Related]
2. Effects of green tea extract and (-)-epigallocatechin-3-gallate on pharmacokinetics of nadolol in rats.
Misaka S; Miyazaki N; Fukushima T; Yamada S; Kimura J
Phytomedicine; 2013 Nov; 20(14):1247-50. PubMed ID: 23920278
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory Effects of Green Tea and (-)-Epigallocatechin Gallate on Transport by OATP1B1, OATP1B3, OCT1, OCT2, MATE1, MATE2-K and P-Glycoprotein.
Knop J; Misaka S; Singer K; Hoier E; Müller F; Glaeser H; König J; Fromm MF
PLoS One; 2015; 10(10):e0139370. PubMed ID: 26426900
[TBL] [Abstract][Full Text] [Related]
4. Effect of epigallocatechin-3-gallate, major ingredient of green tea, on the pharmacokinetics of rosuvastatin in healthy volunteers.
Kim TE; Ha N; Kim Y; Kim H; Lee JW; Jeon JY; Kim MG
Drug Des Devel Ther; 2017; 11():1409-1416. PubMed ID: 28533679
[TBL] [Abstract][Full Text] [Related]
5. Preparation and antioxidant activity of green tea extract enriched in epigallocatechin (EGC) and epigallocatechin gallate (EGCG).
Hu J; Zhou D; Chen Y
J Agric Food Chem; 2009 Feb; 57(4):1349-53. PubMed ID: 19182914
[TBL] [Abstract][Full Text] [Related]
6. Role of (-)-epigallocatechin gallate in the pharmacokinetic interaction between nadolol and green tea in healthy volunteers.
Abe O; Ono T; Sato H; Müller F; Ogata H; Miura I; Shikama Y; Yabe H; Onoue S; Fromm MF; Kimura J; Misaka S
Eur J Clin Pharmacol; 2018 Jun; 74(6):775-783. PubMed ID: 29480324
[TBL] [Abstract][Full Text] [Related]
7. Black tea extract and theaflavin derivatives affect the pharmacokinetics of rosuvastatin by modulating organic anion transporting polypeptide (OATP) 2B1 activity.
Kondo A; Narumi K; Okuhara K; Takahashi Y; Furugen A; Kobayashi M; Iseki K
Biopharm Drug Dispos; 2019 Sep; 40(8):302-306. PubMed ID: 31400238
[TBL] [Abstract][Full Text] [Related]
8. Curcumin as a permeability enhancer enhanced the antihyperlipidemic activity of dietary green tea extract.
Pandit AP; Joshi SR; Dalal PS; Patole VC
BMC Complement Altern Med; 2019 Jun; 19(1):129. PubMed ID: 31196040
[TBL] [Abstract][Full Text] [Related]
9. Lack of pharmacokinetic interaction between fluvastatin and green tea in healthy volunteers.
Misaka S; Abe O; Sato H; Ono T; Shikama Y; Onoue S; Yabe H; Kimura J
Eur J Clin Pharmacol; 2018 May; 74(5):601-609. PubMed ID: 29368187
[TBL] [Abstract][Full Text] [Related]
10. Study on the pharmacokinetics of deoxyschizandrin and schizandrin in combination with epigallocatechin gallate, a component of green tea, in rats.
Liu Y; Zhang D; Wang Y; Zhang W; Liu X
Xenobiotica; 2018 Apr; 48(4):412-421. PubMed ID: 28471331
[TBL] [Abstract][Full Text] [Related]
11. An Appraisal of Drug-Drug Interactions with Green Tea (Camellia sinensis).
Albassam AA; Markowitz JS
Planta Med; 2017 Apr; 83(6):496-508. PubMed ID: 28118673
[TBL] [Abstract][Full Text] [Related]
12. Effects of EGCG content in green tea extract on pharmacokinetics, oxidative status and expression of inflammatory and apoptotic genes in the rat ocular tissues.
Chu KO; Chan KP; Yang YP; Qin YJ; Li WY; Chan SO; Wang CC; Pang CP
J Nutr Biochem; 2015 Nov; 26(11):1357-67. PubMed ID: 26362107
[TBL] [Abstract][Full Text] [Related]
13. Safety assessment of green tea based beverages and dried green tea extracts as nutritional supplements.
Dekant W; Fujii K; Shibata E; Morita O; Shimotoyodome A
Toxicol Lett; 2017 Aug; 277():104-108. PubMed ID: 28655517
[TBL] [Abstract][Full Text] [Related]
14. Interactions of green tea catechins with organic anion-transporting polypeptides.
Roth M; Timmermann BN; Hagenbuch B
Drug Metab Dispos; 2011 May; 39(5):920-6. PubMed ID: 21278283
[TBL] [Abstract][Full Text] [Related]
15. Gly45 and Phe555 in Transmembrane Domains 1 and 10 Are Critical for the Activation of Organic Anion Transporting Polypeptide 1B3 by Epigallocatechin Gallate.
Yue M; Yang J; Jin M; Steiert B; Xiang Y; Zhang H; Hagenbuch B; Gui C
J Agric Food Chem; 2019 Aug; 67(32):9079-9087. PubMed ID: 31353905
[TBL] [Abstract][Full Text] [Related]
16. Impact of Bioconversion of Gallated Catechins and Flavonol Glycosides on Bioaccessibility and Intestinal Cellular Uptake of Catechins.
Choi EH; Rha CS; Balusamy SR; Kim DO; Shim SM
J Agric Food Chem; 2019 Feb; 67(8):2331-2339. PubMed ID: 30767525
[TBL] [Abstract][Full Text] [Related]
17. Lipid rafts mediate epigallocatechin-3-gallate- and green tea extract-dependent viability of human colon adenocarcinoma COLO 205 cells; clusterin affects lipid rafts-associated signaling pathways.
Pajak B; Kania E; Gajkowska B; Orzechowski A
J Physiol Pharmacol; 2011 Aug; 62(4):449-59. PubMed ID: 22100846
[TBL] [Abstract][Full Text] [Related]
18. Green tea epigallocatechin gallate binds to and inhibits respiratory complexes in swelling but not normal rat hepatic mitochondria.
Weng Z; Zhou P; Salminen WF; Yang X; Harrill AH; Cao Z; Mattes WB; Mendrick DL; Shi Q
Biochem Biophys Res Commun; 2014 Jan; 443(3):1097-104. PubMed ID: 24384371
[TBL] [Abstract][Full Text] [Related]
19. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
James KD; Forester SC; Lambert JD
Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
[TBL] [Abstract][Full Text] [Related]
20. Impact of Green Tea Catechin Ingestion on the Pharmacokinetics of Lisinopril in Healthy Volunteers.
Misaka S; Ono Y; Uchida A; Ono T; Abe O; Ogata H; Sato H; Suzuki M; Onoue S; Shikama Y; Shimomura K
Clin Transl Sci; 2021 Mar; 14(2):476-480. PubMed ID: 33048477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
